Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation

Canadian Respiratory Journal

Volumn 22, Issue 4, 2015, Pages 225-229

  Dajczman, Esther ^a,b,c   Wardini, Rima ^a   Kasymjanova, Goulnar ^b   Préfontaine, David ^a,c   Baltzan, Marc Alexander ^a,c   Wolkove, Norman ^a,b,c  

^a and a member of the Respiratory Medicine Program Committee of the College of Family Physicians of Canada   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

6MWD; COPD; Mortality; Pulmonary rehabilitation

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; ENDURANCE TRAINING; EXERCISE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PULMONARY REHABILITATION; RESISTANCE TRAINING; SIX MINUTE WALK DISTANCE TEST; SURVIVAL PREDICTION; SURVIVAL TIME; WALKING; COHORT ANALYSIS; EXERCISE TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY CARE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; VITAL CAPACITY;

AGED; COHORT STUDIES; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84938343403     PISSN: 11982241     EISSN: 19167245     Source Type: Journal    
DOI: 10.1155/2015/280187     Document Type: Article

References (28)

1. World Health Organization. Ten leading causes of death in the world, 2010-2012. Geneva: World Health Organization. (Accessed August 4, 2014).
2. Hoyert DL, Xu J. Deaths: Preliminary Data for 2011. National Vital Statistics Report 2012. Natl Vital Stat Rep 2012;61:1-51.
3. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. (Accessed August 2014).
4. Celli BR. Predictors of mortality in COPD. Respir Med 2010;104:773-9.
5. Cote CG, Pinto-Plata VM, Marin JM, Nekach H, Dordelly LJ, Celli BR. The modified BODE index: Validation with mortality in COPD. Eur Respir J 2008;32:1269-74.
6. Martinez FJ, Foster, G, Curtis JL et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Resp Crit Care 2006;173:1326-34.
7. Casanova C, Coté, C, Marin, JM, et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008;134:746-52.
8. Salzman SH. The 6-Min Walk Test: Clinical and research role, technique, coding, and reimbursement. Chest 2009;135:1345-52.
9. Pinto-Plata VM, Coté, C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: Change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;23:28-33.
10. Lisboa BC, Barria PP, Yanez VJ, Aguire ZM, Diaz PO. [Six minute walk for the assessment of patients with chronic obstructive pulmonary disease.] Rev Med Chil 2008;136:1056-64.
11. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Crit Care Med 2002;166:111-7.
12. Zanini A, Chetta A, Gumiero F, et al. Six-minute walking distance improvement after pulmonary rehabilitation is associated with baseline lung function in complex COPD patients: A retrospetive study. BioMed Res Int 2013:1-6.
13. Polkey MI, Martijn A, Spruit LD, et al. Six-minute-walk test in chronic obstructive pulmonary disease: Minimally clinically important difference for death or hospitalization. Am J Resp Crit Care 2013;187:382-6.
14. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. (Accessed August 15, 2013).
15. Allison PD. Survival Analysis Using the SAS System. A Practical Guide, 2nd edn. Cary: SAS Institute, 2010.
16. Jager K, van Dyke PC, Zoccali C, Dekker FW. The analysis of survival data: The Kaplan-Meier method. Kidney Int 2008;74:560-5.
17. Butland RJ., Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ 1982;284:1607-8.
18. Kasymjanova G, Correa JA, Kreisman H, et al. Prognostic value of the 6 MWD in advanced non-small cell lung cancer. J Thorac Oncol 2009;4:602-7.
19. Miyamoto S, Niagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Resp Crit Care 2000;161:487-92.
20. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009;103:117-23.
21. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD. Chest 2011;140:331-42.
22. Enfield K, Gammon S, Floyd J, et al. Six-minute walk distance in patients with severe end-stage COPD: Association with survival after inpatient pulmonary rehabilitation. J Cardiopulm Rehabil Prev 2010;30:195-202.
23. Spruit MA, Polkey MI, Celli BR, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012;13:291-7.
24. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR. The 6 min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007;132:1778-85
25. Provencio M, Isla D, Sánchez A, Cantos B. Inoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine. J Thorac Dis 2011;3:197-204.
26. Vokes EE. Optimal therapy for unresectable stage III non-small-cell lung cancer. J Clin Oncol 2005;23:5853-5.
27. Sequist LV, Joshi VA, Jãnne PA, et al. Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing. Oncologist 2007;12:90-8.
28. Brooks D, Sottana R, Bell B, et al. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J 2007;14:87-92.